PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsLansoprazole
Lansoprazole
/ / Lansoprazole, Lansoprazole, Prevacid (lansoprazole) is a small molecule pharmaceutical. Lansoprazole was first approved as Prevacid on 1995-05-10. It is used to treat duodenal ulcer, esophagitis, gastroesophageal reflux, helicobacter infections, and stomach ulcer amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
neoplasmsD009369
digestive system diseasesD004066
Trade Name
FDA
EMA
Lansoprazole, Prevacid (discontinued: Lansoprazole, Prevacid)
Combinations
Lansoprazole, amoxicillin clarithromycin (discontinued: Lansoprazole, amoxicillin clarithromycin, Prevacid naprapac, Prevpac)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Lansoprazole
Tradename
Company
Number
Date
Products
LANSOPRAZOLEDexcel PharmaN-208025 OTC2016-06-07
1 products
PREVACID 24 HRPerrigoN-022327 OTC2009-05-18
1 products, RLD, RS
PREVACIDTakedaN-020406 RX1995-05-10
1 products, RLD, RS
PREVACIDTakedaN-021428 RX2002-08-30
2 products, RLD, RS
Show 3 discontinued
Lansoprazole
+
Naproxen
Tradename
Company
Number
Date
Products
PREVACID NAPRAPAC 250 (COPACKAGED)TakedaN-021507 DISCN2003-11-14
1 products, RLD
PREVACID NAPRAPAC 375 (COPACKAGED)TakedaN-021507 DISCN2003-11-14
1 products
PREVACID NAPRAPAC 500 (COPACKAGED)TakedaN-021507 DISCN2003-11-14
1 products
Hide discontinued
Amoxicillin
+
Clarithromycin
+
Lansoprazole
Tradename
Company
Number
Date
Products
PREVPAC (COPACKAGED)TakedaN-050757 DISCN1997-12-02
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
basic care lansoprazoleANDA2025-02-05
berkley and jensen lansoprazoleANDA2025-02-14
careone acid reducerANDA2025-05-15
dg health lansoprazoleANDA2025-03-04
equaline lansoprazoleANDA2025-02-13
equate lansoprazoleANDA2025-03-14
equate lansoprazole delayed releaseANDA2020-05-06
foster and thrive acid reducerANDA2023-09-14
good neighbor pharmacy lansoprazoleANDA2025-12-01
good sense lansoprazoleNew Drug Application2025-01-29
Show 14 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
gastroesophageal refluxEFO_0003948D005764K21
helicobacter infectionsEFO_1000961D016481—
stomach ulcer—D013276K25
duodenal ulcerEFO_0004607D004381K26
zollinger-ellison syndrome—D015043E16.4
esophagitisHP_0100633D004941K20
urinary tract infectionsEFO_0003103D014552N39.0
sinusitisEFO_0007486D012852J32
nontuberculous mycobacterium infectionsEFO_0007461D009165A31.9
otitis mediaEFO_0004992D010033H66.9
Show 29 more
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Lansoprazole, Lansoprazole, Dexcel
110770552036-04-21DP
ATC Codes
A: Alimentary tract and metabolism drugs
— A02: Drugs for acid related disorders
— A02B: Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
— A02BC: Proton pump inhibitors for peptic ulcer and gord
— A02BC03: Lansoprazole
— A02BC53: Lansoprazole, combinations
— A02BD: Combinations for eradication of helicobacter pylori
— A02BD02: Lansoprazole, tetracycline and metronidazole
— A02BD03: Lansoprazole, amoxicillin and metronidazole
— A02BD07: Lansoprazole, amoxicillin and clarithromycin
— A02BD09: Lansoprazole, clarithromycin and tinidazole
— A02BD10: Lansoprazole, amoxicillin and levofloxacin
HCPCS
No data
Clinical
Clinical Trials
312 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———1————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLansoprazole
INNlansoprazole
Description
Lansoprazole is a member of benzimidazoles, a member of pyridines and a sulfoxide. It has a role as an EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor and an anti-ulcer drug.
Classification
Small molecule
Drug classantiulcer agents (benzimidazole derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1
Identifiers
PDB—
CAS-ID103577-45-3
RxCUI—
ChEMBL IDCHEMBL480
ChEBI ID6375
PubChem CID3883
DrugBankDB00448
UNII ID0K5C5T2QPG (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Lansoprazole
+
Amoxicillin
+
Clarithromycin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Lansoprazole
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Lansoprazole
+
Naproxen
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
76,922 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use